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Introduction: With the current hepatitis C (HCV) epidemic in the Appalachian region and the risk 
of human immunodeficiency virus (HIV) co-infection, there is a need for increased secondary 
prevention efforts. The purpose of this study was to implement routine HIV and HCV screenings 
in the urgent care setting through the use of an electronic medical record (EMR) to increase a 
provider’s likelihood of testing eligible patients. 
Methods: From June 2017 through May 2018, EMR-based HIV and HCV screenings were 
implemented in three emergency department-affiliated urgent care settings: a local urgent care 
walk-in clinic; a university-based student health services center; and an urgent care setting located 
within a multi-specialty clinic. EMR best practice alerts (BPA) were developed based on Centers 
for Disease Control and Prevention (CDC) guidelines and populated on registered patients who 
qualified to receive HIV and/or HCV testing. Patients were excluded from the study if they chose to 
opt out from testing or the provider deemed it clinically inappropriate. Upon notification of a positive 
HIV and/or HCV test result through the EMR, patient navigators (PNs) were responsible for linking 
patients to their first medical appointment. 
Results: From June 2017 through May 2018, 48,531 patients presented to the three urgent care 
clinics. Out of 27,230 eligible patients, 1,972 patients (7.2%) agreed to be screened for HIV; for 
HCV, out of 6,509 eligible patients, 1,895 (29.1%)  agreed to be screened. Thirty-one patients 
(1.6%) screened antibody-positive for HCV, with three being ribonucleic acid confirmed positives. 
No patients in either setting were confirmed positive for HIV; however, two initially screened HIV-
positive. PNs were able to link 17 HCV antibody-positive patients (55%) to their first appointment, 
with the remainder having a scheduled future appointment. 
Conclusion: Introducing an EMR-based screening program is an effective method to identify 
and screen eligible patients for HIV and HCV in Appalachian urgent care settings where universal 
screenings are not routinely implemented. [West J Emerg Med. 2018;19(6)1057–1064.]
INTRODUCTION
Hepatitis C virus (HCV) significantly increases the risk 
of developing hepatocellular carcinoma and liver cirrhosis.1 
Treatment of HCV-related illnesses is estimated to cost 
West Virginia University School of Medicine, Department of Emergency Medicine, 
Morgantown, West Virginia
approximately $6.5 billion per year in the United States (U.S.).2 
Individuals born between 1945 and 1965 currently account for 
three-fourths of all HCV infections and are recommended to 
have at least one HCV test in their lifetime, according to Centers 
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Population Health Research Capsule
What do we already know about this issue?
There is a need for increased Hepatitis C 
(HCV) testing in conjunction with CDC 
guidelines in the Appalachian region, due 
to the high co-infection rates among HIV-
positive injection drug users.
What was the research question?
Is an electronic medical record-based 
screening program an effective method to 
identify and screen eligible patients for HIV 
and HCV in urgent care centers?
What was the major finding of the study?
HIV and HCV screenings are feasible during 
routine urgent care patient visits, with 
subsequent successful linkage to care efforts 
for positive patients.
How does this improve population health?
Early identification and intervention of HCV 
infections may decrease the spread of the 
virus while in early stages, reduce HIV co-
infection rates, and prevent future epidemics. 
for Disease Control and Prevention (CDC) recommendations.3 
Recently, an HCV epidemic related to injection of opioids has led 
to a sharp increase in incident cases in the U.S. 
Central Appalachia (Kentucky, Tennessee, Virginia, West 
Virginia) has been particularly hard hit by this epidemic, with 
observed cases of HCV increasing 364% between 2006 and 
2012.4,5 A recent study has demonstrated a need for further 
HCV testing and intervention in the Appalachian region.6 
Among Central Appalachia states, West Virginia currently 
has the second-highest incident rate of HCV in the nation.4 
Of particular concern is the fact that HCV co-infection 
has been observed in rates as high as 90% among human 
immunodeficiency virus (HIV) positive injection drug users.7 
Although West Virginia has historically had a low HIV 
prevalence, there has recently been an alarming increase of 
HIV cases in the state.8 This increase, coupled with the HCV 
epidemic, demonstrates the need for established screening 
efforts to help halt the cycle of transmission of HIV and HCV.7
One plausible location to increase our HIV and HCV 
screenings are local, acute care, walk-in clinics where research 
has been limited. A recent review of the National Hospital 
Ambulatory Medical Care Survey revealed that HIV testing 
was significantly greater in outpatient ambulatory medical care 
settings than in emergency departments (ED) and physicians’ 
offices, suggesting that urgent cares may be an important setting 
in which to expand testing.9-10 HCV has been identified in 
individuals outside of current CDC recommendations for testing, 
indicating a need to implement universal screening during patient 
visits.11 Multiple studies have demonstrated success in using a 
best practice alert (BPA) model, prompting and streamlining 
the linkage-to-care process.11,12  Additionally, urgent care clinics 
may be an ideal setting for both HIV and HCV screenings, as 
physicians may be less constrained by time or patient acuity 
compared to the ED setting. To our knowledge, there are no 
prior scholarly works discussing the implementation of a dual 
HIV-HCV screening program within an urgent care location, 
especially within rural Appalachian settings.  
The purpose of our study was to implement an electronic 
medical record (EMR)-based HIV and HCV screening program 
at three of our local urgent care clinics with the primary objective 
of  using BPAs to enhance a provider’s likelihood of ordering a 
test in patients eligible for HIV and HCV screenings. A secondary 
objective was to increase the overall number of tests ordered, 
adapting from very minimal to routine testing practices. 
MATERIALS and METHODS
Study Population and Clinical Sites
 The three locations used for the implementation of 
HIV and HCV screenings were two local urgent care clinics 
(one stand alone and one multi-specialty based) and a student 
health services clinic affiliated with a large, mid-Atlantic 
university. The urgent care clinic typically sees approximately 
24,000 patients per year of all ages, with an average 
throughput time of 49.7 minutes. The student health services 
clinic evaluates approximately 70% of the total student 
population (~30,000 per year), with an average throughput 
time of 36.8 minutes. Student health services also has 
approximately 2,000 visits from the general public per year, 
including university faculty and staff. Approximately 2-7% of 
patients seen in these clinics will have blood drawn as a part 
of their care, although a larger proportion receives point-of-
care testing. None of the three walk-in clinics had previously 
conducted preventive screenings during routine patient visits. 
The three sites represent different demographics. 
Although the majority of patients at all three locations have 
private-payer insurance (roughly 50%), the percentage of 
Medicare/Medicaid vs. self-pay varies between the three 
locations and may have affected screening rates. However, 
all screenings were free of charge to patients at all three 
locations, regardless of their insurance status. HIV and/or 
HCV screenings were only performed during a patient visit 
if concerns were identified related to current symptoms or 
when a patient presented for a sexually transmitted infection 
screening. Therefore, the introduction and implementation of 
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HIV and HCV screenings into the urgent care settings would 
allow for these tests to become a routine part of patient visits, 
no longer relying on the clinician-driven method previously 
used. This study was given a non-human subjects research 
designation by our university’s institutional review board. 
The Electronic Medical Record
To introduce routine HIV and HCV screenings into the 
urgent care settings, the EMR (Epic® 2015, Epic Systems 
Corporation) was used. BPAs, a clinical decision tool, were used 
to populate within the charts of registered patients who qualified 
to receive the following: 1) only an HIV screening; 2) only an 
HCV screening; or 3) both an HIV and HCV screening. The 
BPAs were developed based on CDC screening guidelines, which 
include a variety of risk factors.13,14 HIV testing is recommended 
for patients aged 13-64 years at least once a year as part of routine 
healthcare.14 A list of recommended guidelines with risk factors 
warranting HCV screening is shown in the Table. 
The EMR would identify eligible patients by searching 
charts of registered patients to see if they met screening 
guidelines and/or had a history of risk factors in the “Problem 
List” tab. BPAs appeared on the computer screen within the 
EMR upon opening of eligible patients’ charts during their 
visit. Upon presentation of a BPA, providers and staff (i.e., 
physicians, nurses, and technicians) could order the suggested 
screening tests; if they decided to not order the test(s) for 
eligible patients, providers and staff were prompted to choose 
one of the following options: “will assess,” “not clinically 
appropriate,” or “patient refused” (Figure 1). To prepare for the 
implementation providers and staff received education on both 
the BPAs and the screening eligibility criteria at staff meetings .
Table. Hepatits C screening recommendations and risk factors, per CDC guidelines.13
Guidelines Risk factors
HCV testing is recommended for those who: Are adults born from 1945 through 1965 (without prior ascertainment of HCV risk factors)
Are currently injecting drugs
Ever injected drugs, including those who injected once or a few times many years ago
Have certain medical conditions, including persons: 
1. who received clotting factor concentrates produced before 1987
2. who were ever on long-term hemodialysis
3. with persistently abnormal alanine aminotransferase levels (ALT)
4. who have HIV infection
Were prior recipients of transfusions or organ transplants, including persons who:
1. were notified that they received blood from a donor who later tested positive for 
HCV infection
2. received a transfusion of blood, blood components, or an organ transplant 
before July 1992
HCV testing based on a recognized exposure 
is recommended for:
Healthcare, emergency medical, and public safety workers after needle sticks, sharps, or 
mucosal exposures to HCV-positive blood
Children born to HCV-positive women
HCV, Hepatitis C virus; CDC, Centers for Disease Control and Prevention.
Figure 1. Example of the dual HIV-HCV “best practice alert” that 
populates upon patient eligibility, which are seen by providers and 
staff at the urgent care locations.
HIV, human immunodeficiency virus; HCV, hepatitis C virus; CDC, 
Centers for Disease Control and Prevention
Implementation of Screenings
Routine EMR-based HIV and HCV screenings began 
in June 2017 and were free of charge to all eligible patients. 
Placards were hung in care rooms, triage areas, and restrooms 
to inform patients of the current screenings, providing them 
the opportunity to opt out from testing. If eligible, providers 
and nursing staff discussed the options of screenings privately 
with patients in their respective treatment rooms. In addition 
to having the option to opt out from HIV and/or HCV 
testing, other exclusions included providers’ decisions on the 
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populated BPAs, and patients refusing a venipuncture during 
their visit. If patients refused a blood draw, an option for a 
third-generation oral fluid HIV antibody test at the student 
health services clinic was offered, with results available within 
20 minutes. Patients also had the option to opt out from the 
oral fluid antibody test, if desired. 
Upon patient verbal consent, blood samples or oral 
swabs were obtained from eligible patients for HIV and/
or HCV testing. The HIV screening test used is a fourth-
generation combined antigen and antibody chemiluminescent 
immunoassay test that reflexes automatically to an antibody 
differentiation immunoassay. All positives obtained from the 
rapid testing are confirmed with the combined antigen and 
antibody testing by the laboratory. The HCV screening test 
used is a chemiluminescent microparticle immunoassay 
performed on ARCHITECTi®. The test reflexes 
automatically to quantitative HCV ribonucleic acid (RNA) 
testing if the initial test result is positive. Results were 
available within 12 hours. 
Patient Navigators and Linkage to Care 
Patients were initially contacted by the urgent care 
provider with results and follow-up instructions. Upon 
receiving notification of a positive HIV and/or HCV screening 
result in the EMR “in-basket” pool, PNs then were responsible 
for linking patients to their appropriate care needs. PNs would 
call patients via phone to discuss 1) that patients had spoken to 
a provider and were aware of their results; 2) the availability 
of follow-up appointment options; and 3) scheduling their 
follow-up appointment with the appropriate clinic.
HCV Linkage-to-care Process
Patients were referred for follow-up appointments with a 
university-based, infectious diseases clinic upon an initial HCV 
antibody-positive screening result. Regardless of confirmatory 
testing status, it can be helpful to counsel patients about risk-
factor modification in the event they are currently “negative” for 
HCV infection. Therefore, PNs would make initial contact with 
HCV antibody-positive patients regardless of confirmatory-
test outcomes. Patients could also be referred to a university-
based, behavioral medicine and psychiatry clinic or a digestive 
diseases clinic, depending on patient preferences or the 
specified care plan of referring providers.  
HIV Linkag- to-care Process
Patients who initially screened positive for HIV with a 
negative or indeterminate confirmatory test were contacted 
and encouraged to have repeat testing in six weeks due to the 
risk of early infection. When possible, these patients were 
scheduled to return to one of our primary locations. PNs 
were responsible for linking confirmed HIV-positive patients 
to a university-based, infectious diseases “Positive Health 
Clinic” for follow-up appointments.15 The Positive Health 
Clinic provides comprehensive, primary HIV care services 
to a largely rural, impoverished, medically underserved area, 
where access to care is limited. 
Transportation Assistance
In order to support patient linkage to care, PNs offered 
transportation assistance and coordination with follow-up 
clinic schedulers. PNs would coordinate taxis with patients 
who did not have their own means of transportation or 
provide information on local bus transit routes close to their 
residence. In addition, PNs would offer gasoline gift cards 
to those who had a reliable source of transportation but 
needed transportation assistance. In terms of scheduling, PNs 
worked closely with clinic schedulers in university-based 
departments of infectious diseases, and behavioral medicine 
and psychiatry, and in the urgent cares to quickly get patients 
into follow-up appointments. 
Data Analysis
We analyzed collected data descriptively to assess the 
progress of the implementation with the goal to provide 
feedback to provider and nursing staff. Reports on BPA firings 
were also conducted via the EMR to provide feedback to staff. 
We tracked counts of the number of patients tested at each 
site, as well as counts of the number of positive test results 
for HIV and HCV. Rates of positivity for HIV and HCV 
screenings were calculated, as well as the linkage-to-care rates 
for all positive patients identified at all locations. 
RESULTS
Prior to implementation, approximately 1,639 HIV 
screenings and 150 HCV screenings were conducted at the 
clinics between June 2016—May 2017. The majority of HIV 
screenings were rapid tests (86%) and occurred at the student 
health services clinic (89%). From June 5, 2017—May 31, 
2018, a total of 48,531 patients presented to the three urgent 
care clinics, with the majority (51%) presenting to the local, 
stand-alone urgent care clinic. The multi-specialty urgent 
care clinic began conducting screenings in February 2018, 
once it opened in September 2017. The BPAs populated on 
36,389 patients eligible for HIV screening (75%). Overall, 
3,388 patients (9.3%) refused HIV screenings, with 5,771 
patients (15.9%) deemed “not clinically appropriate” through 
the BPAs by providers. Additionally, the BPAs populated 
on 7,465 patients eligible for HCV screening (24%), with 
489 patients (4.2%) deemed “not clinically appropriate’”by 
providers. Furthermore, a total of 467 patients (4.0%) 
refused HCV screenings.
Of the remaining 27,230 patients eligible, 1,972 agreed to 
be screened for HIV (7.2%). Similarly, of the remaining 6,509 
patients eligible, 1,895 (29.1%) agreed to be screened for 
HCV (Figure 2). The student health services clinic had higher 
screening rates for both HIV and HCV compared to the local 
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Figure 2. Flowchart of HIV and HCV screenings at all urgent care clinics. 
HIV, human immunodeficiency virus; HCV, Hepatitis C virus; RNA; ribonucleic acid.
urgent care clinics, with 70% of all screenings occurring at 
student health. Since screenings were not included as part of 
the acute sick visit, no initial baseline numbers are available 
for preventative health screenings in comparison. 
Thirty-one patients (1.6%) screened antibody-positive for 
HCV, with three (9.7%) subsequently having a positive RNA 
result. The average age of HCV antibody-positive patients 
was 25 years, ranging from 18-65 years. All patients with 
antibody-positive HCV results were referred to infectious 
diseases for follow-up through our PNs. No patients in any 
of the three clinics were confirmed positive for HIV during 
this time period. However, two patients had an initial positive 
screen with a negative confirmatory result.  Our PNs were able 
to link 17 patients (55%) to their first appointments during this 
time, with the remaining 14 (45%) patients having a scheduled 
future appointment. 
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DISCUSSION
Our study demonstrated that an EMR-based HIV and 
HCV screening program is effective in the Appalachian 
urgent care settings. The “opt-out” model of testing allowed 
these varying locations to successfully increase screenings 
in conjunction with CDC guidelines and increase linkage 
to care through the use of PNs. The EMR is effective at 
identifying eligible patients to be screened for HIV and 
HCV, as demonstrated in the number of BPA firings during 
the initial four months. 
During the initial implementation, there were relatively 
low acceptance rates for both HIV and HCV testing by 
our patient population. There are a number of factors as 
to why initial patient testing was low. If providers and 
staff were choosing “will assess” upon firing of the BPAs, 
instead of immediately addressing it, the BPAs would 
continue to populate on the same patients until one of the 
following occurred: the test was ordered; it was considered 
not clinically necessary by the provider; or the patient 
refused to be tested. In cases where only “will assess” was 
chosen, it is possible that a final decision for the screenings 
may not have been addressed, as it was not required for 
chart closure. In these cases, documentation for reasoning 
was frequently unrecorded. For those patients who were 
documented as “not clinically appropriate” or “patient 
refusal,” some indicated that they would defer testing, since 
no additional blood work was indicated at the time of visit. 
With a low percentage of patients typically having 
blood drawn during a visit and short throughput times, 
patients do not want to spend the “extra” time giving blood. 
A practical alternative would be to reinforce the availability 
of the oral swab test to those patients, which could help 
increase the HIV testing rates. Other patients indicated a 
desire to discuss testing with their primary care provider 
or felt they were low risk and testing was unnecessary. 
Finally, due to the strong, negative stigma still surrounding 
HIV and HCV, patients may not want to know if they are 
positive for either. In some cases, the tests were ordered 
but not directly from the BPA if later decided. Although 
there was a comment option on the BPA, it was rarely used 
by the providers to capture the additional reasons noted 
above. It may be beneficial to require reasoning on the 
BPA in order to close the patient chart, as well as enforce 
consistent responses from all providers and nursing staff, to 
generate the most accurate reports of the BPA results.
BPA fatigue is often a problem in clinical locations due 
to multiple documentation requirements. In the urgent care 
settings, these BPAs are somewhat limited when compared 
to inpatient services and outpatient primary care. Our 
current EMR administration has addressed some of these 
needs in the background that are not readily apparent to 
the practitioner. In these cases, certain documentation is 
required prior to chart closure without prompting a BPA 
alert. Due to this, our location was likely more successful 
than others by implementing this method. Although we 
did not survey staff perceptions about the implementation 
of routine HIV and HCV testing, physicians, advanced 
practice providers, and nursing staff seemed willing 
to participate when education of the department was 
performed during departmental meetings. Testing was 
performed under all providers and orders seemed to 
increase with ongoing education.
There were a number of challenges with the EMR. 
First, the accuracy and completeness of searchable, 
historical data in the EMR affected the accuracy of BPA 
firings. If the patient’s past medical history or current 
problem list was not up to date, BPAs would populate 
unnecessarily or repeatedly in the case of those patients 
who had been previously tested. Risk factors that were not 
captured by the EMR, such as multiple sexual partners and 
injection drug use, represented missed opportunities for 
screening. These behaviors were often not addressed in the 
patient visits unless indicated by initial patient complaints. 
If addressed at a previous visit, the information may have 
been documented within the body of the provider note as 
free-text and not in a location that could be easily accessed 
via the EMR logic for the BPA requirements. Also, BPAs 
were initially set to only detect prior blood screenings. 
During this study period, past oral HIV antibody testing 
was not captured by the BPAs. However, upon review of 
the BPA data, patients who had refused initial blood work 
but consented for an oral HIV antibody swab were not 
counted in the totals; therefore, in future we would like to 
adjust the BPA to capture these tests.
Challenges with EMR data have been previously 
reported in the literature.16,17 Despite the commonly held 
belief that EMRs decrease medical errors by providing 
complete patient information and history, inaccuracies and 
incompleteness are a frequently occurring problem. One 
study found that 25% of patient charts were incomplete, 
with the most commonly inaccurate fields being current 
medications, medical history, and medical allergies.16 
In a study by Tse and You, inaccuracies in medications 
were reported in 51% of records.17 While over 91% of 
participants had a history summary with eight or less items 
present, omissions were reported for one in every five 
participants.17 Further work is needed to improve EMR 
accuracy, especially when implementing widespread, EMR-
based routine screening for infectious diseases.
Since the BPAs were designed around CDC guidelines 
for screenings, there is the possibility that some patient 
populations could be missed. Of particular interest are 
those who are younger than the HCV birth cohort of 52-
72 years of age. Although baby boomers account for the 
majority of existing infections, newly diagnosed HCV 
infections are increasing most rapidly among 20-29 year 
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olds.14,18 The urgent care providers were recognizing risk 
factors not previously noted in the EMR, and thus began 
using wider screening efforts than the original BPA design. 
For example, if the BPA was triggered by patient eligibility 
for an HIV screening, providers would also recommend 
an HCV screening to the patient, since they would already 
be having blood drawn upon verbal consent. Interestingly, 
all of the HCV antibody-positive patients were younger 
than the birth cohort, with an average age of 24 years, 
ranging from 18-38 years. This may be related to the 
HCV epidemic that the Appalachian region is currently 
enduring. The initial findings support the need for universal 
HCV screenings among this population, since birth cohort 
screening does not identify a significant portion of people 
infected with HCV.18  
PNs played a crucial role in the screening program. All 
10 patients (100%) who tested HCV-antibody positive were 
successfully scheduled with referrals to infectious diseases 
for follow-up. Although 90% of those patients did not have 
HCV RNA-positive results, it is important for the patients to 
attend their follow-up appointments due to possibly having a 
previous infection. These follow-up appointments also present 
an opportunity to counsel “negative” patients on risk-factor 
modification. Our linkage-to-care rate was significantly higher 
than what is currently seen in the literature.19,20 In a recent 
EMR review from a large healthcare system, no action was 
taken in 30% of patients who tested positive for HCV.16 Other 
studies have demonstrated that only about 15% of patients 
diagnosed with chronic HCV have received treatment.20 A 
possible explanation for our successful linkage-to-care rate 
could be the PN transportation assistance. Transportation is a 
significant issue with patients in the Appalachian population; 
therefore, providing financial assistance has benefitted our 
population tremendously.
Their successes notwithstanding, the PNs have faced 
a number of challenges. PNs discovered that patients were 
more likely to attend their infectious diseases follow-up 
appointments if scheduled close to their original urgent 
care visit. Initially, PNs and schedulers could get patients 
in within four weeks of initial visit. However, both PNs and 
schedulers have become more efficient in scheduling these 
appointments closer to within two weeks of initial visit. 
This has been a common issue for patient care coordinators 
in other settings; the longer the delay to getting a follow-up 
appointment, the less likely a patient is to attend.18 Patients 
who are motivated to seek treatment will sustain this wait; 
however, those patients who lack motivation or education are 
less likely to wait and will eventually fail to access care.18 
Additionally, PNs could only interface with patients when 
contact information was available to them in the EMR. 
Therefore, if patients did not provide sufficient or correct 
contact information upon initial presentation to the clinic, 
the PNs could not follow up with them in a timely manner, 
if at all. To improve follow-up we suggest that clinic staff 
encourage patients to provide multiple modes of contact 
upon registration with front-desk staff at these clinics.
Future Directions and Improvements
Although initial implementation has been successful, 
there are many areas to improve and expand upon. First, 
patient-reported reasons for not having HIV and/or HCV 
screenings conducted during their visit should be documented 
in provider and staff notes within the patients’ EMR. This 
would allow tracking of patient perceptions. Similarly, 
surveying all patients on their opinions of HIV and HCV 
screenings during their visits, regardless of whether or 
not they were tested, would increase insight into patient 
perceptions. This could provide feedback on the opt-out 
process for testing, as well as on the placards hanging in all 
treatment rooms and triage locations. Surveying providers 
and staff on their opinions and perceptions of the screening 
program would be valuable for improving the screening 
process. It is crucial to continuously gain feedback from those 
on the front lines of implementation in order to best tweak the 
program to what will be most efficient for both the patients, 
and the providers and nursing staff. It is also important to 
have multiple risk factors recorded in easily accessible areas 
of the EMR so the BPA will populate accurately.
CONCLUSION
This study has demonstrated the feasibility of introducing 
an EMR-based method to identify and screen eligible patients 
for HIV and HCV in Appalachian urgent care settings, 
successfully transitioning from conducting essentially no 
screenings to making this a part of routine patient visits within 
a 12-month period. Other urgent or acute care clinics in the 
Appalachian region should consider adopting a similar practice 
to manage the side effects of the current opioid epidemic.
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